NewsBenzingaCytokinetics Presents Additional Data From Assessment Comparing Aficamten To Placebo On Cardiac Endpoints In Adults With Non-Obstructive HCM At HFSA Annual Scientific Meeting 2026 Cytokinetics Presents Additional Data From Assessment Comparing Aficamten To Placebo On Cardiac Endpoints In Adults With Non-Obstructive HCM At HFSA Annual Scientific Meeting 2026 Benzinga 2026.10.12 20:02 (GMT+0) Open on Benzinga Other news Anthropic's Q3 Revenue Surged 45% to $16.8 Billion, Profitable on Adjusted Basis as Dario Amodei Courts Investors: Report Fox, Roku Shareholders Approve $22B Merger – What Happens Next? - TipRanks.com ValuEngine Energy Sector Analysis Elon Musk Sees ‘Almost All Cars’ Going Electric as Gasoline-Only Vehicles Fall Below Half of Global Sales Anthony Scaramucci Defends Elon Musk Over Ukraine Starshield Disruption, Says ‘Questions Should Be Addressed to the Trump Admin’ Figma announces new features to define how agents work on its platform
Anthropic's Q3 Revenue Surged 45% to $16.8 Billion, Profitable on Adjusted Basis as Dario Amodei Courts Investors: Report
Elon Musk Sees ‘Almost All Cars’ Going Electric as Gasoline-Only Vehicles Fall Below Half of Global Sales
Anthony Scaramucci Defends Elon Musk Over Ukraine Starshield Disruption, Says ‘Questions Should Be Addressed to the Trump Admin’
